SUBSCRIBE
SUBSCRIBE
News   Business

Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated’s Board of Directors

July 8, 2009 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that Jeffrey Leiden, M.D., Ph.D. and Dennis Winger joined its board of directors.
People
Vertex Pharmaceuticals
MORE ON THIS TOPIC
A piggy bank crammed with $100 bills on a background of American cash
Series B
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
December 1, 2025
 · 
1 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Valneva Terminates 30 Amid Site Closure
December 1, 2025
 · 
92 min read
 · 
BioSpace Editorial Staff
Planning strategy and ways to achieve business goals, searching for new opportunities for high results, direction of career development, the path to great success, man changes direction on signpost.
Manufacturing
As CGT Struggles To Scale, FDA’s New Designation Could Smooth Post-Approval Pivots
November 25, 2025
 · 
4 min read
 · 
Nick Paul Taylor
Poznan, Poland - 5 October 2024: GSK -Glaxosmithkline headquarters office building in Poznan.
Legal
UPDATE: GSK’s Tesaro Sues AnaptysBio Over Current Jemperli Contract; Anaptys Countersues
November 21, 2025
 · 
3 min read
 · 
Tristan Manalac